Chang Chiung-Wen, Poteet Ethan, Schetz John A, Gümüş Zeynep H, Weinstein Harel
Department of Physiology and Biophysics, Weill Medical College of Cornell University, 1300 York Avenue, New York, NY 10021, USA.
Neuropharmacology. 2009;56 Suppl 1(Suppl 1):213-25. doi: 10.1016/j.neuropharm.2008.07.049. Epub 2008 Aug 13.
Through a multidisciplinary approach involving experimental and computational studies, we address quantitative aspects of signaling mechanisms triggered in the cell by the receptor targets of hallucinogenic drugs, the serotonin 5-HT2A receptors. To reveal the properties of the signaling pathways, and the way in which responses elicited through these receptors alone and in combination with other serotonin receptors' subtypes (the 5-HT1AR), we developed a detailed mathematical model of receptor-mediated ERK1/2 activation in cells expressing the 5-HT1A and 5-HT2A subtypes individually, and together. In parallel, we measured experimentally the activation of ERK1/2 by the action of selective agonists on these receptors expressed in HEK293 cells. We show here that the 5-HT1AR agonist Xaliproden HCl elicited transient activation of ERK1/2 by phosphorylation, whereas 5-HT2AR activation by TCB-2 led to higher, and more sustained responses. The 5-HT2AR response dominated the MAPK signaling pathway when co-expressed with 5-HT1AR, and diminution of the response by the 5-HT2AR antagonist Ketanserin could not be rescued by the 5-HT1AR agonist. Computational simulations produced qualitative results in good agreement with these experimental data, and parameter optimization made this agreement quantitative. In silico simulation experiments suggest that the deletion of the positive regulators PKC in the 5-HT2AR pathway, or PLA2 in the combined 5-HT1A/2AR model greatly decreased the basal level of active ERK1/2. Deletion of negative regulators of MKP and PP2A in 5-HT1AR and 5-HT2AR models was found to have even stronger effects. Under various parameter sets, simulation results implied that the extent of constitutive activity in a particular tissue and the specific drug efficacy properties may determine the distinct dynamics of the 5-HT receptor-mediated ERK1/2 activation pathways. Thus, the mathematical models are useful exploratory tools in the ongoing efforts to establish a mechanistic understanding and an experimentally testable representation of hallucinogen-specific signaling in the cellular machinery, and can be refined with quantitative, function-related information.
通过多学科方法,包括实验研究和计算研究,我们探讨了致幻药物的受体靶点——血清素5-HT2A受体在细胞中触发的信号传导机制的定量方面。为了揭示信号通路的特性,以及单独通过这些受体以及与其他血清素受体亚型(5-HT1AR)联合引发反应的方式,我们建立了一个详细的数学模型,用于模拟在单独表达5-HT1A和5-HT2A亚型以及同时表达这两种亚型的细胞中受体介导的ERK1/2激活。同时,我们通过实验测量了选择性激动剂对HEK293细胞中表达的这些受体的作用所引起的ERK1/2激活。我们在此表明,5-HT1AR激动剂盐酸沙立普隆通过磷酸化引发ERK1/2的瞬时激活,而TCB-2对5-HT2AR的激活导致更高且更持久的反应。当与5-HT1AR共表达时,5-HT2AR反应主导了MAPK信号通路,并且5-HT2AR拮抗剂酮色林对反应的减弱不能被5-HT1AR激动剂挽救。计算模拟产生的定性结果与这些实验数据高度一致,并且参数优化使这种一致性达到定量。计算机模拟实验表明,在5-HT2AR途径中删除正向调节因子PKC,或在联合的5-HT1A/2AR模型中删除PLA2,会大大降低活性ERK1/2的基础水平。发现在5-HT1AR和5-HT2AR模型中删除MKP和PP2A的负向调节因子具有更强的作用。在各种参数集下,模拟结果表明特定组织中的组成性活性程度和特定药物的疗效特性可能决定5-HT受体介导的ERK1/2激活途径的不同动力学。因此,数学模型是正在进行的努力中的有用探索工具,有助于建立对细胞机制中致幻剂特异性信号传导的机械理解和可实验测试的表征,并且可以用与功能相关的定量信息进行完善。